Authors: Vanessa Ngan, Staff Writer, 2003; Dr Jasmine Mann, ST5 Dermatology Registrar, University Hospitals of Derby and Burton NHS Foundation Trust; Dr Maulina Sharma, Consultant Dermatologist, University Hospitals of Derby and Burton NHS Foundation Trust; Miss Shuchi Dixit, Consultant Gynaecologist, University Hospitals of Derby and Burton NHS Foundation Trust, United Kingdom. Copy edited by Gus Mitchell. April 2021.
Cyclicvulvovaginitis is a descriptive term referring to recurrent burning and itching of the vulva and/or vagina that recurs at the same phase of the menstrual cycle.
The three major causes of cyclic vulvovaginitis are:
Cyclic vulvovaginitis is a clinical diagnosis based on history and examination. The Q-tip test should be performed to check for provoked vulvodynia.
Vaginal swabs and scrapings for smear and culture should be performed during the symptomatic phase and, if negative, again in the asymptomatic phase. If a Candida sp. is cultured, the specific strain and drug sensitivities should be reported.
What is the differential diagnosis for cyclic vulvovaginitis?
Moderate potency topical steroid such as clobetasone butyrate.
Vulvodynia is best managed by a specialist vulval clinic.
What is the outcome for cyclic vulvovaginitis?
The outcome of cyclic vulvovaginitis depends on the cause. Correct identification and treatment can result in resolution of symptoms but may require long-term intermittent or continuous treatment.
Bibliography
Aballéa S, Guelfucci F, Wagner J, et al. Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis (RVVC) in Europe and the USA. Health Qual Life Outcomes. 2013;11:169. doi:10.1186/1477-7525-11-169. Journal
Banerjee AK, de Chazal R. Chronic vulvovaginal pruritus treated successfully with GnRH analogue. Postgrad Med J. 2006;82(970):e22. doi:10.1136/pgmj.2005.043950. PubMed Central
Blostein F, Levin-Sparenberg E, Wagner J, Foxman B. Recurrent vulvovaginal candidiasis. Ann Epidemiol. 2017;27(9):575–82.e3. doi:10.1016/j.annepidem.2017.08.010. PubMed
Geiger AM, Foxman B, Sobel JD. Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida. Genitourin Med. 1995;71(5):304–7. doi:10.1136/sti.71.5.304. PubMed Central
Secor RM. Cytolytic vaginosis: a common cause of cyclic vulvovaginitis. Nurse Pract Forum. 1992;3(3):145–8. PubMed
Sheary B, Dayan L. Recurrent vulvovaginal candidiasis. Aust Fam Physician. 2005;34(3):147–50. PubMed
Suresh A, Rajesh A, Bhat RM, Rai Y. Cytolytic vaginosis: a review. Indian J Sex Transm Dis AIDS. 2009;30(1):48–50. doi:10.4103/0253-7184.55490 PubMed Central
Yano J, Sobel JD, Nyirjesy P, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019;19(1):48. doi:10.1186/s12905-019-0748-8. Journal